Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 13 Jun 2022

The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database

in Respiratory Pharmacology

Rui Yang
Tao Huang
Longbin Shen
Aozi Feng
Li Li
Shuna Li
Liying Huang
Ningxia He
Wei Huang
Hui Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.869499

15,276 views
13 citations

Original Research

Published on 08 Jun 2022

The Association Between Bronchoscopy and the Prognoses of Patients With Ventilator-Associated Pneumonia in Intensive Care Units: A Retrospective Study Based on the MIMIC-IV Database

in Respiratory Pharmacology

Luming Zhang
Shaojin Li
Shiqi Yuan
Xuehao Lu
Jieyao Li
Yu Liu
Tao Huang
Jun Lyu
Haiyan Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.868920

7,323 views
6 citations

Original Research

Published on 08 Jun 2022

Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

in Respiratory Pharmacology

Fangbo Zhang
Feifei Guo
Yang Liu
Yi Zhang
Defeng Li
Hongjun Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.903593

3,096 views
10 citations

Original Research

Published on 07 Jun 2022

Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice

in Respiratory Pharmacology

Hanjing Sheng
Gang Lin
Shengxian Zhao
Weibin Li
Zhaolin Zhang
Weidong Zhang
Li Yun
Xiaoyang Yan
Hongyu Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.771031

5,873 views
18 citations

Review

Published on 03 Jun 2022

Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis

in Respiratory Pharmacology

Hongbo Ma
Shengming Liu
Shanrui Li
Yong Xia

Frontiers in Pharmacology

doi 10.3389/fphar.2022.918771

9,289 views
31 citations

Original Research

Published on 03 Jun 2022

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score

in Respiratory Pharmacology

Jochen G. Mainz
Carlos Zagoya
Louise Polte
Lutz Naehrlich
Lenny Sasse
Olaf Eickmeier
Christina Smaczny
Anton Barucha
Lilith Bechinger
Franziska Duckstein

Frontiers in Pharmacology

doi 10.3389/fphar.2022.877118

6,792 views
52 citations

Clinical Trial

Published on 02 Jun 2022

The Efficacy and Safety of Remimazolam Tosilate Versus Dexmedetomidine in Outpatients Undergoing Flexible Bronchoscopy: A Prospective, Randomized, Blind, Non-Inferiority Trial

in Respiratory Pharmacology

Xingfang Chen
Deqian Xin
Guangjun Xu
Jing Zhao
Qing Lv

Frontiers in Pharmacology

doi 10.3389/fphar.2022.902065

5,221 views
34 citations

Original Research

Published on 02 Jun 2022

Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis

in Respiratory Pharmacology

Yanru Wang
Xiaojie Jin
Qin Fan
Chenghao Li
Min Zhang
Yongfeng Wang
Qingfeng Wu
Jiawei Li
Xiuzhu Liu
Siyu Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.879268

4,040 views
14 citations

Original Research

Published on 02 Jun 2022

Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis

in Respiratory Pharmacology

Lloyd Tanner
Jesper Bergwik
Andrew B. Single
Ravi K. V. Bhongir
Jonas S. Erjefält
Arne Egesten

Frontiers in Pharmacology

doi 10.3389/fphar.2022.899469

4,240 views
5 citations

Original Research

Published on 01 Jun 2022

Chloroquine Attenuates Asthma Development by Restoring Airway Smooth Muscle Cell Phenotype Via the ROS-AKT Pathway

in Respiratory Pharmacology

Yan Ren
Xiuhua Zhong
Hongyu Wang
Zhongqi Chen
Yanan Liu
Xiaoning Zeng
Yuan Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2022.916508

3,841 views
6 citations

Opinion

Published on 31 May 2022

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia

in Respiratory Pharmacology

Shan Shen
Ning Hou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.921307

1,823 views
2 citations

Original Research

Published on 31 May 2022

Age-Related Increase of Collagen/Fibrin Deposition and High PAI-1 Production in Human Nasal Polyps

in Respiratory Pharmacology

Ara Jo
Tae Gyu Choi
Jung Yeon Han
Mark H. Tabor
Narasaiah Kolliputi
Richard F. Lockey
Seong H. Cho

Frontiers in Pharmacology

doi 10.3389/fphar.2022.845324

3,608 views
7 citations

Original Research

Published on 31 May 2022

Supplementation With Spirulina platensis Improves Tracheal Reactivity in Wistar Rats by Modulating Inflammation and Oxidative Stress

in Respiratory Pharmacology

Aline de F. Brito
Alexandre S. Silva
Alesandra A. de Souza
Paula B. Ferreira
Iara L. L. de Souza
Layanne C. da C. Araujo
Bagnólia A. da Silva

Frontiers in Pharmacology

doi 10.3389/fphar.2022.826649

2,403 views
4 citations

Original Research

Published on 26 May 2022

S-Nitroso-L-Cysteine Stereoselectively Blunts the Deleterious Effects of Fentanyl on Breathing While Augmenting Antinociception in Freely-Moving Rats

in Respiratory Pharmacology

Paulina M. Getsy
Santhosh M. Baby
Ryan B. Gruber
Benjamin Gaston
Tristan H. J. Lewis
Alan Grossfield
James M. Seckler
Yee-Hsee Hsieh
James N. Bates
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2022.892307

2,266 views
18 citations

Original Research

Published on 20 May 2022

TRAF6 Suppresses the Development of Pulmonary Fibrosis by Attenuating the Activation of Fibroblasts

in Respiratory Pharmacology

Jiali Min
Qiao Li
Suosi Liu
Qianrong Wang
Min Yin
Yan Zhang
Jun Yan
Bing Cui
Shanshan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.911945

2,840 views
5 citations

Original Research

Published on 20 May 2022

The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs

in Respiratory Pharmacology

Dan-Li Hao
Ya-Jie Wang
Jia-Ying Yang
Ran Xie
Ling-Yu Jia
Jin-Tang Cheng
Hai Ma
Ji-Xiang Tian
Shan-Shan Guo
Ting Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.860492

4,380 views
10 citations